Micron Recognized as Innovation Shaping the Future of Infectious Disease at BioFuture 2023

October 7, 2023

Micron CEO, Steve Damon, joined an impressive group of innovators at at BioFuture2023, one of the leading conferences on the future of healthcare, to discuss the most important innovations impacting immediate and long-term global priorities in preventing and treating infectious diseases. The panel, which featured prominent voices in the industry including former Director of the Department of Health and Human Services’ Prevention & Response, Dr. Rick Bright, PhD; Dr. Elizabeth Kavaler and Karim Lalji reflected, among other things, on the opportunity to make vaccines and treatments more accessible globally and in the United States.